צימודים חיסוניים של אינטרלוקין-2, אגוניסט cd40, ואנטגוניסט קושר ציר pd-1 אופציונלי לשימוש בשיטות לטיפול בסרטן
- 专利权人:
- F. HOFFMANN-LA ROCHE AG
- 发明人:
- 申请号：
- IL26955819
- 公开号：
- IL269558D0
- 申请日:
- 2019.09.23
- 申请国别(地区):
- IL
- 年份:
- 2019
- 代理人:
- 摘要：
- The invention provides compositions and methods for treating cancer, the method comprising administering an IL-2 immunoconjugate, a CD40 agonist and optionally a PD-1 axis binding antagonist.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- COMBINATION THERAPY COMPRISING OX40 BINDING AGONISTS AND PD-1 AXIS BINDING ANTAGONISTS
- Combination therapy comprising OX40 binding agonists and PD-1 axis binding antagonists
- COMBINATION THERAPY COMPRISING OX40 BINDING AGONISTS AND PD-1 AXIS BINDING ANTAGONISTS
- COMBINATION THERAPY COMPRISING OX40 BINDING AGONISTS AND PD-1 AXIS BINDING ANTAGONISTS
- COMBINATION THERAPY COMPRISING OX40 BINDING AGONISTS AND PD-1 AXIS BINDING ANTAGONISTS
